MedTrace Logo

RCT of Misoprostol for Postpartum Hemorrhage in India

NCT00097123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2014-07-31

No results posted yet for this study

Summary

Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.

Conditions

  • Postpartum Hemorrhage
  • Pregnancy

Interventions

DRUG

Misoprostol

Sponsors & Collaborators

  • Global Network for Women's and Children's Health Research

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • RTI International

    collaborator OTHER

  • University of Missouri-Columbia

    collaborator OTHER

  • Jawaharlal Nehru Medical College

    collaborator OTHER

  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Principal Investigators

  • Richard J Derman, M.D. · University of Missouri-Columbia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00097123 on ClinicalTrials.gov